Steven Elms

Steven Elms

Presidente en ADMA BIOLOGICS, INC. .

Fortuna: 823 976 $ al 31/08/2026

62 años
Health Technology
Finance
Health Services

Perfil

Steven Arnote Elms is currently Chairman at ADMA Biologics, Inc. since 2012.
He is an Independent Director at Marker Therapeutics, Inc. since 2019 and serves on the Board of Directors at Ajax Health LLC.
He is Director at Marker Cell Therapy, Inc. since 2019, Director at Ajax Health II LLC, Director at Treeline Biosciences, Inc., Managing Partner at Aisling Capital LLC since 2000, Managing Member at Aisling Capital Partners LLC, and Member-INVO Board at Northwestern University.
Former positions include Chairman at MAP Pharmaceuticals LLC from 2004 to 2011, Co-Chairman at LENSAR, Inc., Chairman at Adams Respiratory Therapeutics, Inc. from 2001 to 2006, Chairman at Oculex Pharmaceuticals, Inc., Chairman at Elevation Oncology, Inc. from 2020 to 2025, Director at Bioenvision, Inc. from 2002 to 2007, Director at Advion BioSciences, Inc., Director at Avera Pharmaceuticals, Inc. from 2004 to 2013, Director at Ambit Biosciences Corp.
from 2001 to 2014, Independent Director at TRIA Beauty, Inc. from 2012 to 2013, Director at CeNeRx BioPharma, Inc., Director at NextWave Pharmaceuticals, Inc., Director at Earlens Corp., Director at Advion, Inc., Director at Novazyme Pharmaceuticals, Inc., Director at Medical Knowledge Group LLC, Director at Scerene Healthcare, Inc., Director at Archimica Cooperatief UA, Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2011 to 2016, Independent Director at Zosano Pharma Corp.
from 2018 to 2022, Independent Director at Loxo Oncology, Inc. from 2013 to 2019, Independent Director at Cidara Therapeutics, Inc. from 2014 to 2015, Principal at Hambrecht & Quist Group, Consultant at Wilkerson Group, Principal at Marion Laboratories, and Principal-Life Sciences Investment Banking Group at Hambrecht & Quist.
Education includes undergraduate studies at Stanford University and an MBA from Kellogg School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 87.330 ( 0,04 % ) 820 029 $ 31/08/2026
01/03/2026 2.968 ( 0,02 % ) 3 947 $ 31/08/2026

Cargos activos de Steven Elms

EmpresasCargoInicio
ADMA BIOLOGICS, INC. Presidente 30/03/2012
MARKER THERAPEUTICS, INC. Director/Miembro de la Junta 06/08/2019
Aisling Capital Partners LLC
Corporate Officer/Principal -
Director/Miembro de la Junta 06/08/2019
Corporate Officer/Principal -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Inversor de Capital Privado 01/07/2000

Antiguos cargos conocidos de Steven Elms.

EmpresasCargoFin
░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Steven Elms.

Formación de Steven Elms.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

58

Relaciones de 1er grado

37

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas37

Finance

Health Services

Health Technology

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Aisling Capital Partners LLC

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Services

Health Technology

Consumer Services

Distribution Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Hambrecht & Quist

Finance

Commercial Services

Finance

Health Technology

Health Technology

ÚLTIMAS HORA | -40%. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN